_id
6915f021bc934aba376b1faf
Ticker
RNAC
Name
Cartesian Therapeutics Inc.
Exchange
NASDAQ
Address
7495 New Horizon Way, Frederick, MD, United States, 21703
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.cartesiantherapeutics.com
Description
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA CAR-T directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, an autologous anti-BCMA mRNA CAR-T to treat autoimmune diseases, such as relapsed/refractory multiple myeloma. The company is headquartered in Frederick, Maryland.
Last Close
8.45
Volume
289404
Current Price
8.52
Change
0.8284023668639088
Last Updated
2025-12-03T13:02:33.188Z
Image
data:image/webp;base64,UklGRjwDAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSGsBAAABoBDJVljBOhKuhEhAAhIiAQmREAdIiIRIQAISkHAlnN39px6pe7+AiJgAfG0vyceQ9+V/Z8lGL2nKEvSSBTYFvWSBTUE/ssCm4LQssCn4poEtwSsNigs/0uASHGGO+/fLgCFYoyxuvsChRhTfGQAewRKkjc0K4FA9yLevWIma4JHnUGeI896uAKDuCA8/vACMOOOLO9a59lYBsOJ8bZQtz6lKnkc4gtbN/xjlE2RwswPoqgbh7gAq5UDQe6fBlqpR9m1SdiS1STmR1CalW5aX0guSdkovSFopvSCpLXUi603ZAaBuWhAXbgAebs4YjfIGgLHDGK+y/zT/zVsMFy/SGuWdp6r6/1DqfrCTH/YA5Zf7ixEA6gJQfM/PCFM8yNuFJyqCZx4sMUSpv0dpghVA5+YIgiUWgLHDKE2wA9dOj4IheCLt4cJLGjRBL2nQBWdJg0fQSxqbgl6ywKYgWxbYUEwDPOlwObnO7wAAVlA4IKoBAABwCwCdASpAAEAAPrFInEmnJCKhM/M9UOAWCWwAwQt3/AcpTu7FMdrNq+oDlZv0z9wHmA/Yj1ev676gPQA/wHUAegB5cPshf4DzgAp0ALIi6OnmakeW7SsmZyRo8yjNFJu4hvJAAP7+hvY/3kEb+tkQ0QM7o/vDf7Snh+QHmXeTobBcyqB3/Q3slkRtpWrujgqYsuUb3z5yf+gaYf/7io79QwYmgj/HyYJyHymX02kqpKqSieTe7vsNcXY1pd9n+HUeZWTyivsdE8OApxBVcCL//NvfzF8pzkZQKSYqgH+P0fwbX7wqMenzws9Yh/JD7SvsR2qD91q6CIXSiTB0LP35US5lMs2fz7QGv1P5tg/jVeHccMlV3vv3jEZ/B/tzCOGPLxuzPhpJf7sCKPD2B2PTKR/1/sBYmSKRGoon0fCxFKr+T6Wv//uKjYKYp7V7mDVCbxTaGc2QlKEl+zk7ys0J9XOZZdoZZkbACfvJU4loRqa9pGI/AKP8YqEfjELT04MPf0DlC17tM6CHRc9qD+KjHYk2vqMO6u7FvDEidn0OyhyY8nwStPdAAAA=
Ipo Date
2016-06-22T00:00:00.000Z
Market Cap
174484192
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.25
Target Price
35.2857
Strong Buy
4
Buy
2
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
452000
Cost Of Revenue
12797000
Gross Profit
-12345000
Operating Expenses
8721000
Operating Income
-21066000
Interest Expense
-
Pretax Income
-35902000
Net Income
-35902000
Eps
-1.3806925783485928
Dividends Per Share
-
Shares Outstanding
26003606
Income Tax Expense
-
EBITDA
-35296000
Operating Margin
-4660.619469026549
Total Other Income Expense Net
-14836000
Cash
143384000
Short Term Investments
-
Receivables
722000
Inventories
-
Total Current Assets
147260000
Property Plant Equipment
17366000
Total Assets
372675000
Payables
2225000
Short Term Debt
3876000
Long Term Debt
-
Total Liabilities
408519000
Equity
-35844000
Depreciation
606000
Change In Working Capital
530000
Cash From Operations
-15600000
Capital Expenditures
1292000
Cash From Investing
-1292000
Cash From Financing
-38000
Net Change In Cash
-16940000
PE
-
PB
-6.180801245396719
ROE
100.16181229773463
ROA
-9.633594955390084
FCF
-16892000
Fcf Percent
-37.3716814159292
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
2
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
4.5
Growth Investing Score
5
Momentum Investing Score
3.5
Net Net Investing Score
1.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
452000
Quarters > 0 > income Statement > cost Of Revenue
12797000
Quarters > 0 > income Statement > gross Profit
-12345000
Quarters > 0 > income Statement > operating Expenses
8721000
Quarters > 0 > income Statement > operating Income
-21066000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-35902000
Quarters > 0 > income Statement > net Income
-35902000
Quarters > 0 > income Statement > eps
-1.3806925783485928
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
26002892
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-35296000
Quarters > 0 > income Statement > operating Margin
-4660.619469026549
Quarters > 0 > income Statement > total Other Income Expense Net
-14836000
Quarters > 0 > balance Sheet > cash
143384000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
722000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
147260000
Quarters > 0 > balance Sheet > property Plant Equipment
17366000
Quarters > 0 > balance Sheet > total Assets
372675000
Quarters > 0 > balance Sheet > payables
2225000
Quarters > 0 > balance Sheet > short Term Debt
3876000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
408519000
Quarters > 0 > balance Sheet > equity
-35844000
Quarters > 0 > cash Flow > net Income
-35902000
Quarters > 0 > cash Flow > depreciation
606000
Quarters > 0 > cash Flow > change In Working Capital
530000
Quarters > 0 > cash Flow > cash From Operations
-15600000
Quarters > 0 > cash Flow > capital Expenditures
1292000
Quarters > 0 > cash Flow > cash From Investing
-1292000
Quarters > 0 > cash Flow > cash From Financing
-38000
Quarters > 0 > cash Flow > net Change In Cash
-16940000
Quarters > 0 > ratios > PE
-1.3806925783485928
Quarters > 0 > ratios > PB
-6.180801245396719
Quarters > 0 > ratios > ROE
100.16181229773463
Quarters > 0 > ratios > ROA
-9.633594955390084
Quarters > 0 > ratios > FCF
-16892000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-37.3716814159292
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
298000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
298000
Quarters > 1 > income Statement > operating Expenses
22109000
Quarters > 1 > income Statement > operating Income
-21811000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
15886000
Quarters > 1 > income Statement > net Income
15886000
Quarters > 1 > income Statement > eps
0.6006673434603846
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
26447251
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
16475000
Quarters > 1 > income Statement > operating Margin
-7319.127516778523
Quarters > 1 > income Statement > total Other Income Expense Net
37697000
Quarters > 1 > balance Sheet > cash
160324000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
354000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
163395000
Quarters > 1 > balance Sheet > property Plant Equipment
17449000
Quarters > 1 > balance Sheet > total Assets
388893000
Quarters > 1 > balance Sheet > payables
454000
Quarters > 1 > balance Sheet > short Term Debt
3790000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
391420000
Quarters > 1 > balance Sheet > equity
-2527000
Quarters > 1 > cash Flow > net Income
15886000
Quarters > 1 > cash Flow > depreciation
589000
Quarters > 1 > cash Flow > change In Working Capital
-1508000
Quarters > 1 > cash Flow > cash From Operations
-17521000
Quarters > 1 > cash Flow > capital Expenditures
2595000
Quarters > 1 > cash Flow > cash From Investing
-2595000
Quarters > 1 > cash Flow > cash From Financing
60000
Quarters > 1 > cash Flow > net Change In Cash
-20044000
Quarters > 1 > ratios > PE
0.6006673434603846
Quarters > 1 > ratios > PB
-89.1692040047487
Quarters > 1 > ratios > ROE
-628.6505738029284
Quarters > 1 > ratios > ROA
4.084928245044267
Quarters > 1 > ratios > FCF
-20116000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-67.50335570469798
Quarters > 1 > health Score
33
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1100000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
1100000
Quarters > 2 > income Statement > operating Expenses
22989000
Quarters > 2 > income Statement > operating Income
-21889000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-17710000
Quarters > 2 > income Statement > net Income
-17710000
Quarters > 2 > income Statement > eps
-0.683713828507894
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
25902650
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-20733000
Quarters > 2 > income Statement > operating Margin
-1989.9090909090908
Quarters > 2 > income Statement > total Other Income Expense Net
4179000
Quarters > 2 > balance Sheet > cash
180434000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1765000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
185120000
Quarters > 2 > balance Sheet > property Plant Equipment
15525000
Quarters > 2 > balance Sheet > total Assets
409130000
Quarters > 2 > balance Sheet > payables
2097000
Quarters > 2 > balance Sheet > short Term Debt
3704000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
430919000
Quarters > 2 > balance Sheet > equity
-21789000
Quarters > 2 > cash Flow > net Income
-17710000
Quarters > 2 > cash Flow > depreciation
1156000
Quarters > 2 > cash Flow > change In Working Capital
-7082000
Quarters > 2 > cash Flow > cash From Operations
-23108000
Quarters > 2 > cash Flow > capital Expenditures
1075000
Quarters > 2 > cash Flow > cash From Investing
-1075000
Quarters > 2 > cash Flow > cash From Financing
-8025000
Quarters > 2 > cash Flow > net Change In Cash
-32176000
Quarters > 2 > ratios > PE
-0.683713828507894
Quarters > 2 > ratios > PB
-10.128531736197163
Quarters > 2 > ratios > ROE
81.27954472440221
Quarters > 2 > ratios > ROA
-4.328697480018576
Quarters > 2 > ratios > FCF
-24183000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-21.984545454545454
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-759000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-759000
Quarters > 3 > income Statement > operating Expenses
25972000
Quarters > 3 > income Statement > operating Income
-26731000
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
-9966000
Quarters > 3 > income Statement > net Income
-10253000
Quarters > 3 > income Statement > eps
-0.3957602203349576
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
25907101
Quarters > 3 > income Statement > income Tax Expense
287000
Quarters > 3 > income Statement > EBITDA
-9480000
Quarters > 3 > income Statement > operating Margin
3521.8708827404475
Quarters > 3 > income Statement > total Other Income Expense Net
16765000
Quarters > 3 > balance Sheet > cash
212610000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
872000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
216626000
Quarters > 3 > balance Sheet > property Plant Equipment
15447000
Quarters > 3 > balance Sheet > total Assets
435023000
Quarters > 3 > balance Sheet > payables
288000
Quarters > 3 > balance Sheet > short Term Debt
2851000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
441825000
Quarters > 3 > balance Sheet > equity
-6802000
Quarters > 3 > cash Flow > net Income
-10253000
Quarters > 3 > cash Flow > depreciation
486000
Quarters > 3 > cash Flow > change In Working Capital
6847000
Quarters > 3 > cash Flow > cash From Operations
-7002000
Quarters > 3 > cash Flow > capital Expenditures
705000
Quarters > 3 > cash Flow > cash From Investing
-354000
Quarters > 3 > cash Flow > cash From Financing
783000
Quarters > 3 > cash Flow > net Change In Cash
-6588000
Quarters > 3 > ratios > PE
-0.3957602203349576
Quarters > 3 > ratios > PB
-32.450529332549245
Quarters > 3 > ratios > ROE
150.73507791825932
Quarters > 3 > ratios > ROA
-2.356886877245571
Quarters > 3 > ratios > FCF
-7707000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
10.154150197628459
Quarters > 3 > health Score
49
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
38913000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
38913000
Annuals > 0 > income Statement > operating Expenses
82810000
Annuals > 0 > income Statement > operating Income
-43897000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-77137000
Annuals > 0 > income Statement > net Income
-77424000
Annuals > 0 > income Statement > eps
-3.268317218080518
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
23689255
Annuals > 0 > income Statement > income Tax Expense
287000
Annuals > 0 > income Statement > EBITDA
-75986000
Annuals > 0 > income Statement > operating Margin
-112.80805900341788
Annuals > 0 > income Statement > total Other Income Expense Net
-33240000
Annuals > 0 > balance Sheet > cash
212610000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
872000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
216626000
Annuals > 0 > balance Sheet > property Plant Equipment
15447000
Annuals > 0 > balance Sheet > total Assets
435023000
Annuals > 0 > balance Sheet > payables
288000
Annuals > 0 > balance Sheet > short Term Debt
2851000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
441825000
Annuals > 0 > balance Sheet > equity
-6802000
Annuals > 0 > cash Flow > net Income
-77424000
Annuals > 0 > cash Flow > depreciation
1151000
Annuals > 0 > cash Flow > change In Working Capital
-5791000
Annuals > 0 > cash Flow > cash From Operations
-23674000
Annuals > 0 > cash Flow > capital Expenditures
9093000
Annuals > 0 > cash Flow > cash From Investing
-8742000
Annuals > 0 > cash Flow > cash From Financing
168428000
Annuals > 0 > cash Flow > net Change In Cash
135991000
Annuals > 0 > ratios > PE
-3.268317218080518
Annuals > 0 > ratios > PB
-23.368847552190534
Annuals > 0 > ratios > ROE
1138.2534548662159
Annuals > 0 > ratios > ROA
-17.797679662914376
Annuals > 0 > ratios > FCF
-32767000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.842057924087066
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
26004000
Annuals > 1 > income Statement > cost Of Revenue
1553000
Annuals > 1 > income Statement > gross Profit
26004000
Annuals > 1 > income Statement > operating Expenses
112420000
Annuals > 1 > income Statement > operating Income
-86416000
Annuals > 1 > income Statement > interest Expense
2833000
Annuals > 1 > income Statement > pretax Income
-238710000
Annuals > 1 > income Statement > net Income
-219710000
Annuals > 1 > income Statement > eps
-42.494476646411954
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
5170319
Annuals > 1 > income Statement > income Tax Expense
-19000000
Annuals > 1 > income Statement > EBITDA
-235034000
Annuals > 1 > income Statement > operating Margin
-332.3181049069374
Annuals > 1 > income Statement > total Other Income Expense Net
-152294000
Annuals > 1 > balance Sheet > cash
76911000
Annuals > 1 > balance Sheet > short Term Investments
-1377000
Annuals > 1 > balance Sheet > receivables
8851000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
90729000
Annuals > 1 > balance Sheet > property Plant Equipment
12181000
Annuals > 1 > balance Sheet > total Assets
305050000
Annuals > 1 > balance Sheet > payables
3150000
Annuals > 1 > balance Sheet > short Term Debt
2166000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
745234000
Annuals > 1 > balance Sheet > equity
-440184000
Annuals > 1 > cash Flow > net Income
-219710000
Annuals > 1 > cash Flow > depreciation
843000
Annuals > 1 > cash Flow > change In Working Capital
4971000
Annuals > 1 > cash Flow > cash From Operations
-51161000
Annuals > 1 > cash Flow > capital Expenditures
206000
Annuals > 1 > cash Flow > cash From Investing
34609000
Annuals > 1 > cash Flow > cash From Financing
-13145000
Annuals > 1 > cash Flow > net Change In Cash
-29750000
Annuals > 1 > ratios > PE
-42.494476646411954
Annuals > 1 > ratios > PB
-0.07881440599840066
Annuals > 1 > ratios > ROE
49.91321810879087
Annuals > 1 > ratios > ROA
-72.02425831830848
Annuals > 1 > ratios > FCF
-51367000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-1.975349946162129
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
110777000
Annuals > 2 > income Statement > cost Of Revenue
2037000
Annuals > 2 > income Statement > gross Profit
108740000
Annuals > 2 > income Statement > operating Expenses
94202000
Annuals > 2 > income Statement > operating Income
14538000
Annuals > 2 > income Statement > interest Expense
3031000
Annuals > 2 > income Statement > pretax Income
34770000
Annuals > 2 > income Statement > net Income
35379000
Annuals > 2 > income Statement > eps
8.73107360443861
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
4052079
Annuals > 2 > income Statement > income Tax Expense
-609000
Annuals > 2 > income Statement > EBITDA
39838000
Annuals > 2 > income Statement > operating Margin
13.123662854202585
Annuals > 2 > income Statement > total Other Income Expense Net
20232000
Annuals > 2 > balance Sheet > cash
106438000
Annuals > 2 > balance Sheet > short Term Investments
28164000
Annuals > 2 > balance Sheet > receivables
9858000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
148138000
Annuals > 2 > balance Sheet > property Plant Equipment
14411000
Annuals > 2 > balance Sheet > total Assets
165886000
Annuals > 2 > balance Sheet > payables
316000
Annuals > 2 > balance Sheet > short Term Debt
10084000
Annuals > 2 > balance Sheet > long Term Debt
17786000
Annuals > 2 > balance Sheet > total Liabilities
72058000
Annuals > 2 > balance Sheet > equity
93828000
Annuals > 2 > cash Flow > net Income
35379000
Annuals > 2 > cash Flow > depreciation
1287000
Annuals > 2 > cash Flow > change In Working Capital
-60377000
Annuals > 2 > cash Flow > cash From Operations
-31631000
Annuals > 2 > cash Flow > capital Expenditures
1201000
Annuals > 2 > cash Flow > cash From Investing
-15002000
Annuals > 2 > cash Flow > cash From Financing
39215000
Annuals > 2 > cash Flow > net Change In Cash
-7398000
Annuals > 2 > ratios > PE
8.73107360443861
Annuals > 2 > ratios > PB
0.28977970424606725
Annuals > 2 > ratios > ROE
37.70622841795626
Annuals > 2 > ratios > ROA
21.327297059426353
Annuals > 2 > ratios > FCF
-32832000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.2963792122913601
Annuals > 2 > health Score
69
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
85077000
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
85077000
Annuals > 3 > income Statement > operating Expenses
89674000
Annuals > 3 > income Statement > operating Income
-4597000
Annuals > 3 > income Statement > interest Expense
2844000
Annuals > 3 > income Statement > pretax Income
-9721000
Annuals > 3 > income Statement > net Income
-25687000
Annuals > 3 > income Statement > eps
-8.088360783651856
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3175798
Annuals > 3 > income Statement > income Tax Expense
15966000
Annuals > 3 > income Statement > EBITDA
-5158000
Annuals > 3 > income Statement > operating Margin
-5.403340503308767
Annuals > 3 > income Statement > total Other Income Expense Net
-5124000
Annuals > 3 > balance Sheet > cash
114057000
Annuals > 3 > balance Sheet > short Term Investments
13998000
Annuals > 3 > balance Sheet > receivables
9914000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
144443000
Annuals > 3 > balance Sheet > property Plant Equipment
11971000
Annuals > 3 > balance Sheet > total Assets
159883000
Annuals > 3 > balance Sheet > payables
224000
Annuals > 3 > balance Sheet > short Term Debt
7010000
Annuals > 3 > balance Sheet > long Term Debt
19673000
Annuals > 3 > balance Sheet > total Liabilities
137362000
Annuals > 3 > balance Sheet > equity
22521000
Annuals > 3 > cash Flow > net Income
-25687000
Annuals > 3 > cash Flow > depreciation
1252000
Annuals > 3 > cash Flow > change In Working Capital
-48194000
Annuals > 3 > cash Flow > cash From Operations
-60382000
Annuals > 3 > cash Flow > capital Expenditures
1085000
Annuals > 3 > cash Flow > cash From Investing
-17140000
Annuals > 3 > cash Flow > cash From Financing
52897000
Annuals > 3 > cash Flow > net Change In Cash
-24628000
Annuals > 3 > ratios > PE
-8.088360783651856
Annuals > 3 > ratios > PB
0.9462104071755251
Annuals > 3 > ratios > ROE
-114.05799032014565
Annuals > 3 > ratios > ROA
-16.066123352701663
Annuals > 3 > ratios > FCF
-61467000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.7224866885292147
Annuals > 3 > health Score
16
Valuation > metrics > PE
-1.3806925783485928
Valuation > metrics > PB
-6.180801245396719
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
100.16181229773463
Profitability > metrics > ROA
-24.38000814885237
Profitability > metrics > Net Margin
-79.429203539823
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-34.76237623762376
Risk > final Score
-109
Risk > verdict
High
Liquidity > metrics > Current Ratio
24.13702671693165
Liquidity > metrics > Quick Ratio
24.13702671693165
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
59
Prev Profitabilities > 1
40
Prev Profitabilities > 2
70
Prev Risks > 0
-118
Prev Risks > 1
1
Prev Risks > 2
-190
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:06:52.919Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.7308
Earnings History > 0 > eps Estimate
-0.63
Earnings History > 0 > eps Difference
-0.1008
Earnings History > 0 > surprise Percent
-16
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.7724
Earnings History > 1 > eps Estimate
-0.82
Earnings History > 1 > eps Difference
0.0476
Earnings History > 1 > surprise Percent
5.8049
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.65
Earnings History > 2 > eps Estimate
-0.71
Earnings History > 2 > eps Difference
0.06
Earnings History > 2 > surprise Percent
8.4507
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-05
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.5935
Earnings History > 3 > eps Estimate
-0.8257
Earnings History > 3 > eps Difference
0.2322
Earnings History > 3 > surprise Percent
28.1216
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.42
Earnings History > 4 > eps Estimate
-0.55
Earnings History > 4 > eps Difference
0.13
Earnings History > 4 > surprise Percent
23.6364
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.64
Earnings History > 5 > eps Estimate
-0.09
Earnings History > 5 > eps Difference
0.73
Earnings History > 5 > surprise Percent
811.1111
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-08
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.8
Earnings History > 6 > eps Estimate
-1.42
Earnings History > 6 > eps Difference
0.62
Earnings History > 6 > surprise Percent
43.662
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-07
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.07
Earnings History > 7 > eps Estimate
-0.04
Earnings History > 7 > eps Difference
-0.03
Earnings History > 7 > surprise Percent
-75
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.06
Earnings History > 8 > eps Estimate
-0.06
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-17
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.07
Earnings History > 9 > eps Estimate
-0.08
Earnings History > 9 > eps Difference
0.01
Earnings History > 9 > surprise Percent
12.5
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.14
Earnings History > 10 > eps Estimate
-0.09
Earnings History > 10 > eps Difference
-0.05
Earnings History > 10 > surprise Percent
-55.5556
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-02
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.04
Earnings History > 11 > eps Estimate
-0.07
Earnings History > 11 > eps Difference
0.11
Earnings History > 11 > surprise Percent
157.1429
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-03
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.05
Earnings History > 12 > eps Estimate
-0.01
Earnings History > 12 > eps Difference
-0.04
Earnings History > 12 > surprise Percent
-400
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-04
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.06
Earnings History > 13 > eps Estimate
-0.08
Earnings History > 13 > eps Difference
0.14
Earnings History > 13 > surprise Percent
175
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-05
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.23
Earnings History > 14 > eps Estimate
-0.11
Earnings History > 14 > eps Difference
0.34
Earnings History > 14 > surprise Percent
309.0909
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-10
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.03
Earnings History > 15 > eps Estimate
-0.07
Earnings History > 15 > eps Difference
0.1
Earnings History > 15 > surprise Percent
142.8571
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-09
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.16
Earnings History > 16 > eps Estimate
-0.07
Earnings History > 16 > eps Difference
-0.09
Earnings History > 16 > surprise Percent
-128.5714
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.04
Earnings History > 17 > eps Estimate
-0.12
Earnings History > 17 > eps Difference
0.16
Earnings History > 17 > surprise Percent
133.3333
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.22
Earnings History > 18 > eps Estimate
-0.12
Earnings History > 18 > eps Difference
-0.1
Earnings History > 18 > surprise Percent
-83.3333
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-11
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.14
Earnings History > 19 > eps Estimate
-0.12
Earnings History > 19 > eps Difference
-0.02
Earnings History > 19 > surprise Percent
-16.6667
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-05
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.09
Earnings History > 20 > eps Estimate
0.06
Earnings History > 20 > eps Difference
-0.15
Earnings History > 20 > surprise Percent
-250
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-06
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.25
Earnings History > 21 > eps Estimate
-0.01
Earnings History > 21 > eps Difference
-0.24
Earnings History > 21 > surprise Percent
-2400
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.21
Earnings History > 22 > eps Estimate
-0.28
Earnings History > 22 > eps Difference
0.07
Earnings History > 22 > surprise Percent
25
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-12
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.3
Earnings History > 23 > eps Estimate
-0.21
Earnings History > 23 > eps Difference
-0.09
Earnings History > 23 > surprise Percent
-42.8571
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-08
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.26
Earnings History > 24 > eps Estimate
-0.33
Earnings History > 24 > eps Difference
0.07
Earnings History > 24 > surprise Percent
21.2121
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-08
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.37
Earnings History > 25 > eps Estimate
-0.3
Earnings History > 25 > eps Difference
-0.07
Earnings History > 25 > surprise Percent
-23.3333
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-09
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.31
Earnings History > 26 > eps Estimate
-0.35
Earnings History > 26 > eps Difference
0.04
Earnings History > 26 > surprise Percent
11.4286
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-15
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.65
Earnings History > 27 > eps Estimate
-0.7
Earnings History > 27 > eps Difference
0.05
Earnings History > 27 > surprise Percent
7.1429
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-08
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.71
Earnings History > 28 > eps Estimate
-0.75
Earnings History > 28 > eps Difference
0.04
Earnings History > 28 > surprise Percent
5.3333
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-08
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.84
Earnings History > 29 > eps Estimate
-0.68
Earnings History > 29 > eps Difference
-0.16
Earnings History > 29 > surprise Percent
-23.5294
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-09
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.71
Earnings History > 30 > eps Estimate
-0.54
Earnings History > 30 > eps Difference
-0.17
Earnings History > 30 > surprise Percent
-31.4815
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-15
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
BeforeMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.88
Earnings History > 31 > eps Estimate
-0.56
Earnings History > 31 > eps Difference
-0.32
Earnings History > 31 > surprise Percent
-57.1429
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-11-07
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.63
Earnings History > 32 > eps Estimate
-0.87
Earnings History > 32 > eps Difference
0.24
Earnings History > 32 > surprise Percent
27.5862
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-08-11
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
BeforeMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.85
Earnings History > 33 > eps Estimate
-0.9
Earnings History > 33 > eps Difference
0.05
Earnings History > 33 > surprise Percent
5.5556
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-05-11
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
AfterMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.82
Earnings History > 34 > eps Estimate
-1.28
Earnings History > 34 > eps Difference
0.46
Earnings History > 34 > surprise Percent
35.9375
Earnings History > 35 > period
2016-12-31
Earnings History > 35 > report Date
2017-03-27
Earnings History > 35 > date
2016-12-31
Earnings History > 35 > before After Market
AfterMarket
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.77
Earnings History > 35 > eps Estimate
-0.25
Earnings History > 35 > eps Difference
-0.52
Earnings History > 35 > surprise Percent
-208
Earnings History > 36 > period
2016-09-30
Earnings History > 36 > report Date
2016-11-10
Earnings History > 36 > date
2016-09-30
Earnings History > 36 > before After Market
BeforeMarket
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.43
Earnings History > 36 > eps Estimate
-0.42
Earnings History > 36 > eps Difference
-0.01
Earnings History > 36 > surprise Percent
-2.381
Earnings History > 37 > period
2016-06-30
Earnings History > 37 > report Date
2016-08-09
Earnings History > 37 > date
2016-06-30
Earnings History > 37 > before After Market
AfterMarket
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-2.75
Earnings History > 37 > eps Estimate
-0.47
Earnings History > 37 > eps Difference
-2.28
Earnings History > 37 > surprise Percent
-485.1064
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA CAR-T directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, an autologous anti-BCMA mRNA CAR-T to treat autoimmune diseases, such as relapsed/refractory multiple myeloma. The company is headquartered in Frederick, Maryland.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A683 Capital Management LLC Grows Stock Holdings in Cartesian Therapeutics, Inc. $RNAC Defense World
Read more →Independent Director of Cartesian Therapeutics Picks Up 168% More Stock simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$35.2857
Analyst Picks
Strong Buy
4
Buy
2
Hold
2
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 38.03% of the total shares of Cartesian Therapeutics Inc.
1.
FMR Inc(8.9767%)
since
2025/06/30
2.
MPM Oncology Impact Management LP(2.6383%)
since
2025/06/30
3.
Fidelity Select Biotechnology(2.5604%)
since
2025/07/31
4.
BlackRock Inc(2.5146%)
since
2025/06/30
5.
Siren, L.L.C.(2.1663%)
since
2025/06/30
6.
Vanguard Group Inc(1.909%)
since
2025/06/30
7.
Fidelity Growth Compy Commingled Pl S(1.7803%)
since
2025/07/31
8.
HBM Healthcare Investments AG Ord(1.5969%)
since
2025/06/30
9.
Fidelity Select Health Care(1.4191%)
since
2025/07/31
10.
Fidelity Growth Company Fund(1.3128%)
since
2025/07/31
11.
Vanguard Total Stock Mkt Idx Inv(1.0837%)
since
2025/07/31
12.
Erste Asset Management GmbH(1%)
since
2025/06/30
13.
iShares Russell 2000 ETF(0.922%)
since
2025/08/31
14.
Fidelity Advisor Health Care I(0.8855%)
since
2025/07/31
15.
683 Capital Management LLC(0.8422%)
since
2025/06/30
16.
Geode Capital Management, LLC(0.842%)
since
2025/06/30
17.
State Street Corp(0.7471%)
since
2025/06/30
18.
Citadel Advisors Llc(0.4649%)
since
2025/06/30
19.
Fidelity Growth Company K6(0.4162%)
since
2025/07/31
20.
Fidelity Small Cap Index(0.3567%)
since
2025/06/30
21.
Vanguard Institutional Extnd Mkt Idx Tr(0.3534%)
since
2025/07/31
22.
Fidelity Series Growth Company(0.342%)
since
2025/07/31
23.
Northern Trust Corp(0.319%)
since
2025/06/30
24.
Marshall Wace Asset Management Ltd(0.3178%)
since
2025/06/30
25.
iShares Russell 2000 Value ETF(0.2714%)
since
2025/08/31
26.
Fidelity VIP Health Care Initial(0.219%)
since
2025/07/31
27.
iShares Biotechnology ETF(0.188%)
since
2025/08/31
28.
Fidelity Extended Market Index(0.1768%)
since
2025/07/31
29.
Vanguard Russell 2000 ETF(0.1707%)
since
2025/07/31
30.
GSA Capital Partners LLP(0.16%)
since
2025/06/30
31.
Jacobs Levy Equity Management, Inc.(0.1589%)
since
2025/06/30
32.
State St Russell Sm Cap® Indx SL Cl I(0.122%)
since
2025/08/31
33.
Barclays PLC(0.118%)
since
2025/06/30
34.
Morgan Stanley - Brokerage Accounts(0.1123%)
since
2025/06/30
35.
Freestone Capital Holdings, LLC(0.0997%)
since
2025/06/30
36.
Bank of New York Mellon Corp(0.0961%)
since
2025/06/30
37.
Charles Schwab Investment Management Inc(0.0958%)
since
2025/06/30
38.
Schwab Small Cap Index(0.0957%)
since
2025/07/31
39.
Nuveen, LLC(0.0942%)
since
2025/06/30
40.
NT R2000 Index Fund - NL(0.0861%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.7308
EPS Estimate
-0.63
EPS Difference
-0.1008
Surprise Percent
-16%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.